EWTX Sells Muscular Dystrophy Business to Servier for $1.55B Upfront, Up to $2.65B Total Deal Value
Edgewise Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $34.16
-8.0% in 1h after detection
Post-detection moves
1h
-8.0%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS